IL1B and post-traumatic stress disorder: In animal models of post-traumatic stress disorder (PTSD), S-ketamine has been shown to attenuate pro-inflammatory responses by reducing TNF-α and IL-1β levels in critical brain regions such as the striatum and periaqueductal gray [29].